Merida CSO Deb Kimless Places Peer Reviewed Clinical Article in Journal of Diabetes

Journal of Diabetes & Metabolism, December 11, 2020

Merida's Chief Scientific Officer, Debra Kimless, M.D., recently co-authored and published an article in the Journal of Diabetes & Metabolism entitled "The Effects of Cannabidiol-Based Sublingual Tablets on Diabetic Neuropathic Pain."

After a 21-day study, research found that patients with chronic diabetic neuropathic pain who took CBD sublingual tablets three times a day reported significant reduction in pain as well as signifiancant improvement in sleep quality and a reduction in anxiety and without any adverse drug reactions in patients.

To read and download the full article, click here.